Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity

Acta Biomaterialia

Volumn 11, Issue 1, 2015, Pages 356-367

  Jiang, Ping Lun ^a   Lin, Hung Jun ^a   Wang, Hsiao Wen ^b   Tsai, Wen Yu ^c   Lin, Shen Fu ^c   Chien, Mei Yin ^c   Liang, Pi Hui ^b   Huang, Yi You ^a,c   Liu, Der Zen ^c,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d HSUAN CHUANG UNIVERSITY   (Taiwan)

Author keywords

Antigen delivery; Cancer immunotherapy; Dendritic cell targeted; Galactosylated liposome; Mucosal vaccine

Indexed keywords

ANTIBODIES; ANTIGENS; CYTOLOGY; LIPOSOMES; MAMMALS; TUMORS; VACCINES;

ANTIBODIES RESPONSE; ANTIGEN DELIVERY; ANTITUMOR IMMUNITY; CANCER IMMUNOTHERAPY; DENDRITIC CELL TARGETED; DENDRITICS; GALACTOSYLATED LIPOSOME; INTRANASAL; MUCOSAL VACCINE; OVALBUMINS;

CELLS;

B7 ANTIGEN; CANCER VACCINE; CD86 ANTIGEN; DENDRITIC CELL VACCINE; GALACTOSYLATED LIPOSOME; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; UNCLASSIFIED DRUG; GALACTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL DENSITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR IMMUNITY; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; NEOPLASMS, EXPERIMENTAL; NOSE MUCOSA; PATHOLOGY; TREATMENT OUTCOME;

MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CANCER VACCINES; DENDRITIC CELLS; GALACTOSE; LIPOSOMES; MICE; MICE, INBRED C57BL; NASAL MUCOSA; NEOPLASMS, EXPERIMENTAL; OVALBUMIN; TREATMENT OUTCOME;

EID: 84924990125     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.09.019     Document Type: Article

References (44)

1. Owen RL, Pierce NF, Apple RT, Cray Jr WC. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis 1986;153:1108-18.
2. Gebert A, Steinmetz I, Fassbender S, Wendlandt KH. Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Am J Pathol 2004;164:65-72.
3. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007;25:381-418.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
5. Swartz MA, Hubbell JA, Reddy ST. Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. Semin Immunol 2008;20:147-56.
6. Ma Y, Poisson L, Sanchez-Schmitz G, Pawar S, Qu C, Randolph GJ, et al. Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model. Immunology 2010;130:374-87.
7. Belyakov IM, Moss B, Strober W, Berzofsky JA. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc Natl Acad Sci USA 1999;96:4512-7.
8. Henderson A, Propst K, Kedl R, Dow S. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. Vaccine 2011;29:5304-12.
9. Bhavsar MD, Amiji MM. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract. AAPS PharmSciTech 2008;9:288-94.
10. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol Today 1990;11:89-97.
11. Tafaghodi M, Jaafari MR, Sajadi Tabassi SA. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN. Eur J Pharm Biopharm 2006;64:138-45.
12. Li F, Michalek SM, Dasanayake AP, Li Y, Kirk K, Childers NK. Intranasal immunization of humans with Streptococcus mutans antigens. Oral Microbiol Immunol 2003;18:271-7.
13. Romero EL, Morilla MJ. Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:356-75.
14. Tseng LP, Liang HJ, Deng MC, Lee KM, Pan RN, Yang JC, et al. The influence of liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease. Vet J 2010;185:204-10.
15. Chiou CJ, Tseng LP, Deng MC, Jiang PR, Tasi SL, Chung TW, et al. Mucoadhesive liposomes for intranasal immunization with an avian influenza virus vaccine in chickens. Biomaterials 2009;30:5862-8.
16. Gieseler RK, Marquitan G, Hahn MJ, Perdon LA, Driessen WH, Sullivan SM, et al. DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease. Scand J Immunol 2004;59:415-24.
17. Kojima N, Biao L, Nakayama T, Ishii M, Ikehara Y, Tsujimura K. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. J Controlled Release 2008;129:26-32.
18. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002;2:77-84.
19. Tsuiji M, Fujimori M, Ohashi Y, Higashi N, Onami TM, Hedrick SM, et al. Molecular cloning and characterization of a novel mouse macrophage C-type lectin, mMGL2, which has a distinct carbohydrate specificity from mMGL1. J Biol Chem 2002;277:28892-901.
20. Raes G, Brys L, Dahal BK, Brandt J, Grooten J, Brombacher F, et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukocyte Biol 2005;77:321-7.
21. Denda-Nagai K, Kubota N, Tsuiji M, Kamata M, Irimura T. Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens. Glycobiology 2002;12:443-50.
22. Higashi N, Fujioka K, Denda-Nagai K, Hashimoto S, Nagai S, Sato T, et al. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J Biol Chem 2002;277:20686-93.
23. Wang HW, Jiang PL, Lin SF, Lin HJ, Ou KL, Deng WP, et al. Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization. Acta Biomater 2013;9:5681-8.
24. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-702.
25. Asanuma H, Thompson AH, Iwasaki T, Sato Y, Inaba Y, Aizawa C, et al. Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 1997;202:123-31.
26. Kuper CF, Koornstra PJ, Hameleers DM, Biewenga J, Spit BJ, Duijvestijn AM, et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992;13:219-24.
27. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001;2:1004-9.
28. PorgadorA. StaatsH.F. ItohY. KelsallB.L.Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: Selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue.Infect Immun1998665876-81
29. Porgador A, Staats HF, Itoh Y, Kelsall BL. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue. Infect Immun 1998;66:5876-81.
30. Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012;11:367-79.
31. t Hart BA, Elferink DG, Drijfhout JW, Storm G, van Blooijs L, Bontrop RE, et al. Liposome-mediated peptide loading of MHC-DR molecules in vivo. FEBS Lett 1997;409:91-5.
32. Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 2003;13:293-310.
33. Mohanan D, Slutter B, Henriksen-Lacey M, Jiskoot W, Bouwstra JA, Perrie Y, et al. Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems. J Controlled Release 2010;147:342-9.
34. Geijtenbeek TB, van Vliet SJ, Engering A, t Hart BA, van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 2004;22:33-54.
35. van Kooyk Y. C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans 2008;36:1478-81.
36. Lloyd CM, Murdoch JR. Tolerizing allergic responses in the lung. Mucosal Immunol 2010;3:334-44.
37. Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001;1:220-8.
38. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
39. Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001;2:585-9.
40. Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol 2009;130:27-33.
41. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
42. Ishii M, Kojima N. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization. Glycoconj J 2010;27:115-23.
43. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988;54:777-85.
44. Sandoval F, Terme M, Nizard M, Badoual C, Bureau MF, Freyburger L, et al. Mucosal imprinting of vaccine-induced CD8(+) T cells is crucial to inhibit the growth of mucosal tumors. Sci Transl Med 2013;5. 172ra20.